RayKnowChina Research Map
Shortlist

Other diseases

NGLY1 deficiency

NGLY1 缺乏症

A rare inherited disorder of protein deglycosylation associated with variants in NGLY1.

hospitals in mainland China
2

with a paper from 2016–2025 or a registered study

cities
2

where those hospitals are

open trials in China
0

ClinicalTrials.gov, 13 Nov 2026

Mainland China accounts for 3% of the world's English-language research papers on NGLY1 deficiency, 2021–2025 (6% in 2016–2020), and 0% of the world's registered trials on it have a site in China.

Research activity in public records, not a rating of care and not medical advice. How the numbers are made

2 hospitals in 2 cities

Order: papers led on NGLY1 deficiency, 2021–2025, then A–Z. Research activity, not a rating of care.

A hospital is listed when it led at least 1 papers or 1 trial on NGLY1 deficiency, or was a site in 1 or more trials. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first. Hospitals not listed may also treat it. Definitions

A square is a city. Its size and number are hospitals listed for this disease, not the amount of research. Choose one to show that city in the hospital list and the trial list.

Cities with the most listed hospitals

  1. Shanghai1
  2. Suzhou1

Each opens NGLY1 deficiency in that city.

  1. 0 papers led
    No open trial led
  2. 0 papers led
    No open trial led

0

open trials on NGLY1 deficiency in China

Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 13 Nov 2026, with at least one listed hospital as lead sponsor or site, and at least one listed hospital's site marked open. Check the registry for the current status. Whether someone can take part is decided by the study team.

Trials registered only in China’s own registry (ChiCTR) are not included. Questions to check before asking about a trial

Search ClinicalTrials.gov for NGLY1 deficiency

Additional research sources

Read the linked papers and reports

Where these numbers come from

Papers

2 English-language PubMed papers on NGLY1 deficiency with an author in mainland China, 2021–2025; a hospital led a paper when its first or last author lists it first. Run the PubMed search

Trials

ClinicalTrials.gov records with a listed hospital as lead sponsor or site, as of 13 Nov 2026. ChiCTR is not included. Search ClinicalTrials.gov

Locations

Locations are shown at city centres. Check the hospital’s website for its address.

Suggest a correctionDownload the data (CSV)Definitions